Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and Cytarabine in Relapsed/Refractory ALL
NCT00337168Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 2006
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute lymphoblastic leukemia (ALL), sponsored by SWOG Cancer Research Network. Started Oct 2006; status: completed.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00337168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337168.